Prognostic significance of epithelial-mesenchymal transition in malignant pleural mesothelioma

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 3, 2010, Pages 566-572

  Schramm, Alexandra ^a   Opitz, Isabelle ^a   Thies, Svenja ^a   Seifert, Burkhardt ^b   Moch, Holger ^a   Weder, Walter ^a   Soltermann, Alex ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Epithelial to mesenchymal transition; Histotype; Malignant pleural mesothelioma; Periostin; PTEN; Tissue microarray

Indexed keywords

BETA1 INTEGRIN; EPIDERMAL GROWTH FACTOR RECEPTOR; INTEGRIN LINKED KINASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR RUNX2;

ADULT; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

AGED; CELL ADHESION MOLECULES; EPIDEMIOLOGIC METHODS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLEURAL NEOPLASMS; PROGNOSIS; PTEN PHOSPHOHYDROLASE; TUMOR MARKERS, BIOLOGICAL;

EID: 76449096904     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.08.027     Document Type: Article

References (25)

1. Kang Y., and Massague J. Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118 (2004) 277-279
2. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2 (2002) 442-454
3. Sheng W., Wang G., La Pierre D.P., Wen J., Deng Z., Wong C.K., Lee D.Y., and Yang B.B. Versican mediates mesenchymal-epithelial transition. Mol Biol Cell 17 (2006) 2009-2020
4. Greenburg G., and Hay E.D. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol 95 (1982) 333-339
5. Mimeault M., and Batra S.K. Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies. Ann Oncol 18 (2007) 1605-1619
6. Sos M.L., Koker M., Weir B.A., Heynck S., Rabinovsky R., Zander T., Seeger J.M., Weiss J., Fischer F., Frommolt P., Michel K., Peifer M., Mermel C., Girard L., Peyton M., Gazdar A.F., Minna J.D., Garraway L.A., Kashkar H., Pao W., Meyerson M., and Thomas R.K. PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR. Cancer Res 69 (2009) 3256-3261
7. Tamura M., Gu J., Tran H., and Yamada K.M. PTEN gene and integrin signaling in cancer. J Natl Cancer Inst 91 (1999) 1820-1828
8. Opitz I., Soltermann A., Abaecherli M., Hinterberger M., Probst-Hensch N., Stahel R., Moch H., and Weder W. PTEN expression is a strong predictor of survival in mesothelioma patients. Eur J Cardiothorac Surg 33 (2008) 502-506
9. Soltermann A., Tischler V., Arbogast S., Braun J., Probst-Hensch N., Weder W., Moch H., and Kristiansen G. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 14 (2008) 7430-7437
10. Hinterberger M., Reineke T., Storz M., Weder W., Vogt P., and Moch H. D2-40 and calretinin - a tissue microarray analysis of 341 malignant mesotheliomas with emphasis on sarcomatoid differentiation. Mod Pathol 20 (2007) 248-255
11. Rusch V.W. A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108 (1995) 1122-1128
12. Yan W., and Shao R. Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation. J Biol Chem 281 (2006) 19700-19708
13. Edwards J.G., Swinson D.E., Jones J.L., Waller D.A., and O'Byrne K.J. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma. Lung Cancer 54 (2006) 399-407
14. Garland L.L., Rankin C., Gandara D.R., Rivkin S.E., Scott K.M., Nagle R.B., Klein-Szanto A.J., Testa J.R., Altomare D.A., and Borden E.C. Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol 25 (2007) 2406-2413
15. Butcher J.T., Norris R.A., Hoffman S., Mjaatvedt C.H., and Markwald R.R. Periostin promotes atrioventricular mesenchyme matrix invasion and remodeling mediated by integrin signaling through Rho/PI 3-kinase. Dev Biol 302 (2007) 256-266
16. Bill H.M., Knudsen B., Moores S.L., Muthuswamy S.K., Rao V.R., Brugge J.S., and Miranti C.K. Epidermal growth factor receptor-dependent regulation of integrin-mediated signaling and cell cycle entry in epithelial cells. Mol Cell Biol 24 (2004) 8586-8599
17. Grille S.J., Bellacosa A., Upson J., Klein-Szanto A.J., van Roy F., Lee-Kwon W., Donowitz M., Tsichlis P.N., and Larue L. The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. Cancer Res 63 (2003) 2172-2178
18. King W.G., Mattaliano M.D., Chan T.O., Tsichlis P.N., and Brugge J.S. Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation. Mol Cell Biol 17 (1997) 4406-4418
19. Kuhn B., del Monte F., Hajjar R.J., Chang Y.S., Lebeche D., Arab S., and Keating M.T. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med 13 (2007) 962-969
20. Cole Jr. G.W., Alleva A.M., Zuo J.T., Sehgal S.S., Yeow W.S., Schrump D.S., and Nguyen D.M. Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126. Anticancer Res 26 (2006) 809-821
21. Watzka S.B., Setinek U., Huber M., Cantonati H., Lax F., Watson S., Weigel G., and Muller M.R. Reactivity of integrin-linked kinase in human mesothelial cell proliferation. Interact Cardiovasc Thorac Surg 7 (2008) 107-110
22. Chamulitrat W, Sattayakhom A, Herold-Mended C, Stremmel W. Human papillomavirus 16 E6/E7-immortalized human gingival keratinocytes with epithelial mesenchymal transition acquire increased expression of cIAP-1, Bclx and p27(Kip1). Exp Dermatol 2009 Apr 22. [Epub ahead of print].
23. Li Q.Q., Xu J.D., Wang W.J., Cao X.X., Chen Q., Tang F., Chen Z.Q., Liu X.P., and Xu Z.D. Twist1-mediated adriamycin-induced epithelial-mesenchymal transition relates to multidrug resistance and invasive potential in breast cancer cells. Clin Cancer Res 15 (2009) 2657-2665
24. Kumar P., and Kratzke R.A. Molecular prognostic markers in malignant mesothelioma. Lung Cancer 49 Suppl. 1 (2005) S53-S60
25. Weder W., Stahel R.A., Bernhard J., Bodis S., Vogt P., Ballabeni P., Lardinois D., Betticher D., Schmid R., Stupp R., Ris H.B., Jermann M., Mingrone W., Roth A.D., and Spiliopoulos A. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18 (2007) 1196-1202